Sun Pharma Advanced Research Company Limited (NSE:SPARC)
137.28
-4.95 (-3.48%)
Oct 29, 2025, 11:30 AM IST
NSE:SPARC Market Cap
NSE:SPARC has a market cap or net worth of 46.16 billion as of October 28, 2025. Its market cap has decreased by -31.35% in one year.
Market Cap
46.16B
Enterprise Value
48.83B
Revenue
645.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
137.28
Market Cap Chart
Since July 18, 2007, NSE:SPARC's market cap has increased from 17.19B to 46.16B, an increase of 168.56%. That is a compound annual growth rate of 5.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 46.16B | -29.08% |
| Dec 31, 2024 | 65.08B | -30.07% |
| Dec 29, 2023 | 93.07B | 62.05% |
| Dec 30, 2022 | 57.43B | -24.01% |
| Dec 31, 2021 | 75.58B | 48.86% |
| Dec 31, 2020 | 50.77B | 24.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.28T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.02T |
| Mankind Pharma | 1.00T |
| Fortis Healthcare | 794.63B |
| Alkem Laboratories | 662.99B |